References
- Smith DW, Lemli L, Opitz JM. A Newly Recognized Syndrome of Multiple Congenital Anomalies. J Pediatr 1964;64:210-7. https://doi.org/10.1016/S0022-3476(64)80264-X
- Porter FD. Smith-Lemli-Opitz syndrome: pathogenesis, diagnosis and management. Eur J Hum Genet 2008;16:535-41. https://doi.org/10.1038/ejhg.2008.10
- DeBarber AE, Eroglu Y, Merkens LS, Pappu AS, Steiner RD. Smith-Lemli-Opitz syndrome. Expert Rev Mol Med 2011;13:e24. https://doi.org/10.1017/S146239941100189X
- Nowaczyk MJ, Irons MB. Smith-Lemli-Opitz syndrome: phenotype, natural history, and epidemiology. Am J Med Genet C Semin Med Genet 2012;160C:250-62. https://doi.org/10.1002/ajmg.c.31343
- Kelley RI. Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography/mass spectrometry of 7- dehydrocholesterol in plasma, amniotic fluid and cultured skin fibroblasts. Clin Chim Acta 1995;236:45-58. https://doi.org/10.1016/0009-8981(95)06038-4
- Nowaczyk MJ. Smith-Lemli-Opitz Syndrome Available from: http://www.ncbi.nlm.nih.gov/books/NBK1143/#slo.REF.kelley.1995.45.
- Ko JS, Choi BS, Seo JK, Shin JY, Chae JH, Kang GH, et al. A novel DHCR7 mutation in a Smith- Lemli-Opitz syndrome infant presenting with neonatal cholestasis. J Korean Med Sci 2010;25:159-62. https://doi.org/10.3346/jkms.2010.25.1.159
- Chae JH, Kim KJ, Hwang YS, Ki CS, Kim JW. Identification of a novel DHCR7 mutation in a Korean patient with Smith-Lemli-Opitz syndrome. J Child Neurol 2007;22:1297-300. https://doi.org/10.1177/0883073807307099
- Park MR, Ko JM, Cheon CK, Kim GH, Yoo HW. A case of Smith-Lemli-Opitz syndrome diagnosed by identification of mutations in the 7-dehydrocholesterol reductase (DHCR7) gene. Korean J Pediatr 2008;51:1236-40. https://doi.org/10.3345/kjp.2008.51.11.1236
- Lee HJ, Lee JH, Lee JS, Choe YH. The Smith-Lemli-Opitz syndrome with a G303R/R352W mutation: in an extremely irritable child responsive to cholesterol supplementation. Genes & Genomics 2010;32:9-12. https://doi.org/10.1007/s13258-010-0687-0
- 강준원, 김숙자, 전영미, 강낙헌. Smith-Lemli-Opitz 증후군 2례. J Korean Soc Inhert Metab Dis 2009; 8:3-6.
- Waterham HR, Hennekam RC. Mutational spectrum of Smith-Lemli-Opitz syndrome. Am J Med Genet C Semin Med Genet 2012;160C:263-84. https://doi.org/10.1002/ajmg.c.31346
- Yu H, Patel SB. Recent insights into the Smith-Lemli-Opitz syndrome. Clin Genet 2005;68:383-91. https://doi.org/10.1111/j.1399-0004.2005.00515.x
- Witsch-Baumgartner M, Fitzky BU, Ogorelkova M, Kraft HG, Moebius FF, Glossmann H, et al. Mutational spectrum in the Delta7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome. Am J Hum Genet 2000;66:402-12. https://doi.org/10.1086/302760
- Matsumoto Y, Morishima K, Honda A, Watabe S, Yamamoto M, Hara M, et al. R352Q mutation of the DHCR7 gene is common among Japanese Smith-Lemli-Opitz syndrome patients. J Hum Genet 2005;50:353-6. https://doi.org/10.1007/s10038-005-0267-3
- Correa-Cerro LS, Porter FD. 3beta-hydroxysterol Delta7-reductase and the Smith-Lemli-Opitz syndrome. Mol Genet Metab 2005;84:112-26. https://doi.org/10.1016/j.ymgme.2004.09.017
- Svoboda MD, Christie JM, Eroglu Y, Freeman KA, Steiner RD. Treatment of Smith-Lemli-Opitz syndrome and other sterol disorders. Am J Med Genet C Semin Med Genet 2012;160C:285-94. https://doi.org/10.1002/ajmg.c.31347